Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

Mrinalini Dey, Naveen R, Elena Nikiphorou, Parikshit Sen, Sreoshy Saha, James B Lilleker, Vishwesh Agarwal, Sinan Kardes, Jessica Day, Marcin Milchert, Mrudula Joshi, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O'Callaghan, Minchul Kim, Tulika Chatterjee, Ai Lyn TanAshima Makol, Arvind Nune, Lorenzo Cavagna, Miguel A Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Oliver Distler, John D Pauling, Latika Gupta*, et al , COVAD Study Group

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)

4 Citations (Scopus)

Abstract

[No abstract]
Original languageEnglish
Pages (from-to)e147-e152
Number of pages6
JournalRheumatology (Oxford, England)
Volume62
Issue number5
DOIs
Publication statusPublished - 2 May 2023

Bibliographical note

Publisher Copyright:
© The Author(s) 2022.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Humans
  • COVID-19 Vaccines
  • COVID-19
  • Myositis
  • Autoimmune Diseases
  • Vaccination

Fingerprint

Dive into the research topics of 'Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study'. Together they form a unique fingerprint.

Cite this